Skip to main content

Ideaya Biosciences

IDEAYA Biosciences Inc is an American precision medicine oncology company committed to the discovery and development of targeted therapeutics for cancer treatment. The company utilizes a molecular diagnostics platform to identify patient biomarkers and develop synthetic lethality therapies targeting specific genetic mutations in tumors. Its clinical-stage pipeline includes targeted oncology candidates addressing DNA damage repair, MAT2A inhibition, and other precision oncology mechanisms. Core operations encompass preclinical drug discovery, medicinal chemistry, biomarker research, and clinical trial management. As a clinical-stage biopharmaceutical firm, the company generates minimal commercial revenue and finances its operations through public equity offerings and major pharmaceutical partnerships. IDEAYA holds an emerging position in precision oncology innovation. The company is headquartered in South San Francisco, California, United States, and its common stock trades on the Nasdaq Global Select Market.

9 of the funds FundTelligence covers report a position in Ideaya Biosciences.

Legal name
Ideaya Biosciences Inc
Sector
Health Care
Country
United States
Funds holding it
9
Exposure themes
Precision Medicine & Genomics, Precision Oncology, Precision Therapeutics

Funds holding Ideaya Biosciences

Showing the 8 largest of 9 funds holding it.

Loading...